BioSpace News Archive

Nowadays, dry eye condition is becoming one of the most common faced complaints in the ophthalmologist’s clinic.

Laboratory proficiency testing ascertains the performance of laboratories for specific testing. Rising technological advancement in the field of laboratory testing is expected to provide growth opportunities in the global laboratory proficiency testing market.

Wound irrigation involves a steady supply of solution through an open wound surface to remove debris, achieve wound hydration, and to assist with visual examination.

The growth of the cell lysis and disruption market can be attributable to the large adoption of cell lysis and disruption methods during manufacture of bio-therapeutics and animal-based products.

Innate Pharma SA announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conference

The companies aim to leverage world-leading microbiome technology expertise to bring new therapeutics to this patient community and help more people build families

Eurofins adds virus variant monitoring capabilities to its commercially available SARS-CoV-2 stand-alone test kit portfolio.

Almirall S.A., a global biopharmaceutical company and MC2 Therapeutics, a commercial stage pharmaceutical company developing a new standard within topical therapies for autoimmune and chronic inflammatory conditions, announced an agreement under which MC2 Therapeutics has granted Almirall exclusive European rights to commercialize Wynzora® Cream for treatment of plaque psoriasis.

Pfizer Inc. and BioNTech SE announced an agreement with the European Commission to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union member states.

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, announced that Dr Megan Baldwin, CEO of Opthea, will virtually present and provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 3:40pm ET.